FAITH-MARIE OAKLEY: Open Payments
NPI 1336658392 · NORTH WILKESBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 40 payments from 14 companies in 2025. Trend: 2023 $168 · 2024 $521 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $229 |
| GlaxoSmithKline, LLC. | 6 | $106 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Eisai Inc. | 3 | $63 |
| Novo Nordisk Inc | 3 | $54 |
| PFIZER INC. | 2 | $52 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, BREZTRI, ELIQUIS, REXULTI, Leqembi, GVOKE HYPOPEN, Kerendia.
Industry payments across NC — which companies pay providers there.
